Responses
Original articles
An association between infantile haemangiomas and erythropoietin treatment in preterm infants
Compose a Response to This Article
Other responses
Jump to comment:
- Published on: 22 March 2016
- Published on: 22 March 2016High dose erythropoietin in preterm infants for neuroprotection does not increase the risk for haemangiomaShow More
Based on a retrospective study, Doege et al. reported an increased incidence of haemangioma after treatment with erythropoietin. To verify these results, we did an interim analysis in an on-going prospective randomized placebo-controlled multicentre trial comparing high dose recombinant human erythropoietin (rhEpo) 3,000 U/kg body weight with NaCl 0.9% intravenously at 3, 12-18 and 36-42 hours after birth (NCT00413946)....
Conflict of Interest:
None declared.